Giovanna Schiavoni Selected Research

Anthracyclines

1/2022	Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
11/2015	Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanna Schiavoni Research Topics

Disease

23	Neoplasms (Cancer) 03/2024 - 02/2011
8	Melanoma (Melanoma, Malignant) 01/2021 - 12/2012
6	Infections 01/2020 - 05/2002
4	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2012
3	Inflammation (Inflammations) 01/2023 - 01/2018
3	Hypersensitivity (Allergy) 01/2018 - 09/2013
2	Asthma (Bronchial Asthma) 01/2022 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
1	Virus Diseases (Viral Diseases) 01/2023
1	COVID-19 01/2023
1	Lymphoma (Lymphomas) 01/2021
1	Parasitic Diseases (Parasitic Disease) 01/2020
1	Necrosis 01/2018
1	Carcinogenesis 09/2016
1	Colorectal Neoplasms (Colorectal Cancer) 11/2015
1	Atherosclerosis 01/2015
1	Experimental Melanoma 01/2013
1	Tuberculosis (Tuberculoses) 01/2013
1	Granuloma 01/2013
1	Contact Dermatitis (Eczema, Contact) 03/2004
1	Asymptomatic Diseases 05/2003
1	Carotid Artery Diseases 05/2003

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2023 - 05/2002
5	AlarminsIBA 01/2023 - 01/2018
5	Interferon Type IIBA 01/2022 - 02/2011
5	AntibodiesIBA 10/2020 - 05/2003
5	Interleukin-33IBA 01/2020 - 09/2013
5	AntigensIBA 09/2016 - 03/2004
5	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 10/2014 - 12/2012
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2003
4	ChemokinesIBA 01/2023 - 12/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 02/2011
3	Transcription Factors (Transcription Factor)IBA 10/2014 - 01/2013
2	IntegrinsIBA 10/2022 - 10/2019
2	AnthracyclinesIBA 01/2022 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2003
2	matrigelIBA 01/2020 - 01/2017
2	AllergensIBA 01/2017 - 09/2013
2	Decitabine FDA Link 01/2017 - 12/2012
2	Immunoglobulins (Immunoglobulin)IBA 09/2016 - 05/2003
2	Interferon Regulatory FactorsIBA 10/2014 - 01/2013
1	ChromatinIBA 03/2024
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 10/2020
1	atezolizumabIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Granzymes (Granzyme)IBA 10/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2019
1	Antiviral Agents (Antivirals)IBA 01/2018
1	AldehydesIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2017
1	Air Pollutants (Pollutants, Air)IBA 01/2017
1	Cancer VaccinesIBA 09/2016
1	LigandsIBA 11/2015
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 11/2015
1	Therapeutic UsesIBA 11/2015
1	InterleukinsIBA 01/2015
1	C-Reactive ProteinIBA 01/2015
1	Fibrinogen (Factor I)FDA Link 01/2015
1	Histocompatibility Antigens Class IIBA 12/2013
1	Interleukin-27 (Interleukin 27)IBA 12/2012
1	Chemokine ReceptorsIBA 12/2012
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 06/2006
1	Interferon gamma ReceptorIBA 06/2006

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 02/2011
6	Immunotherapy 03/2024 - 09/2016
3	Lab-On-A-Chip Devices 01/2020 - 11/2015
2	Therapeutics 01/2022 - 01/2020
1	Sublingual Administration 01/2021
1	Intravenous Injections 01/2017
1	Intranasal Administration 01/2017
1	Adjuvant Chemotherapy 11/2015
1	Carotid Endarterectomy 05/2003